BusinessUS FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Phospholipase 2G6 (PLA2G6)-Associated NeurodegenerationBy Nasdaq OMXNov 2, 2017, 1:00 PM UTC
BusinessStudy of Retrotope’s deuterated polyunsaturated fatty acid drugs published in The FEBS JournalBy Nasdaq OMXOct 30, 2017, 1:01 PM UTC
